D. Bouros (Alexandroupolis, Greece), J. Muller-Quernheim (Freiburg, Germany)
Idiopathic interstitial lung disease with anti-ssa/ssb antibodies: a forme fruste of connective tissue disease?
J. F. Boitiaux, M. P. Debray, P. Nicaise-Roland, H. Adle-Biassette, C. Taille, M. Bonnay, S. Marchand-Adam, J. Cadranel, M. Aubier, B. Crestani (Paris, France)
|  |
Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis
B. Salobir, M. Tercelj, B. Wraber, S. Simcic, M. Sabovic (Ljubljana, Slovenia)
| |
Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases
M. Vasakova, M. Sterclova, L. Kolesar, A. Slavcev, P. Pohunek, J. Sulc, J. Skibova, I. Striz (Prague, Czech Republic)
|  |
Diagnostic value of total cell count in bronchoalveolar lavage fluid from patients with interstitial lung diseases
J. Domagala-Kulawik, T. Skirecki, R. Chazan (Warsaw, Poland)
| |
BAL levels of mrp-14 in IIPs
N. Korthagen, C. van Moorsel, N. Barlo, K. Kazemier, J. van den Bosch, J. Grutters (Nieuwegein, Utrecht, Netherlands)
| |
BALF proteomic analysis in polymyositis/dermatomyositis patients with interstitial lung disease
S. Giuliano, F. Meloni, L. Cavagna, S. Soza, I. Passadore, A. Bardoni, R. Salvini, A. Fietta, C. Maurizio (Pavia, Italy)
| |
Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF)
P. Kopinski, B. Balicka-Slusarczyk, G. Przybylski, A. Jarzemska, K. Sladek, T. Iwaniec, K. Szablowska, M. Krawczyk, J. Soja, J. Szczeklik (Bydgoszcz, Krakow, Poland)
| |
Clinical characteristics and follow-up of pulmonary MALT lymphoma
R. Borie, M. Wislez, G. Thabut, A. Rabbat, L. J. Couderc, I. Monnnet, H. Nunes, F. X. Blanc, H. Mal, A. Bergeron, D. Dusser, D. Israel-Biet, B. Crestani, J. Cadranel (Paris, Suresnes, Creteil, Le Kremlin-Bicetre, France)
| |
Collagen and elastic system evaluation in infectious and non-infectious granulomatous lung diseases
E. R. Parra, I. Narde, P. H. Da Silva, W. Zocolaro, V. Capelozzi (São Paulo, Brazil)
| |
Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D
T. Samukwa, T. Hamada, K. Ohara, T. Tsukuya, Y. Higashi, M. Soejima, H. Nagahama, H. Tsubouchi (Kagoshima, Japan)
| |
Profiling of gene expressions induced by TGF-β1 and cyclosporine a in alveolar cells in vitro
N. Hirota, H. Ohta, T. Tamai, S. Homma, T. Nukiwa, M. Ebina (Sendai, Miyagi, Tokyo, Japan)
| |
Differences of angiogenic factors in BALF in ILD
M. Sterclova, M. Vasakova, L. Kolesar, J. Pavlicek, I. Striz (Prague, Czech Republic)
| |
Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis
E. R. Parra, W. Teodoro, J. De Morais, M. Katayama, R. De Souza, N. Yoshinari, V. Luiza (São Paulo, Brazil)
| |
A clinical study of chronic eosinophilic pneumonia (CEP)
T. Mayumi, Y. Mochizuki, Y. Nakahara, T. Kawamura, S. Sasaki, A. Morimoto, H. Tsukamoto, T. Miyagawa, H. Tabata, H. Okada, E. Watanabe, T. Goto, K. Mimura, R. Katsuda (Himeji-shi, Japan)
| |
Immunohistochemical study of Langerhans‘cell histiocytosis
I. Dvorakovskaya, M. Rybakova, E. Martusevich, N. Korzina (St. Petersburg, Russian Federation)
| |
Clinical picture of amiodarone pneumonitis 2001-2008
J. Homolka, V. Jencova, A. Slovakova, P. Stranska (Prague, Czech Republic)
| |
Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/remodelling in emphysema
L. S. MacKay, L. A. Borthwick, K. Pinnion, C. Ward, J. Lordan, M. Foster, A. J. Fisher, P. A. Corris (Newcastle upon Tyne, Loughborough, United Kingdom)
| |
Screening tool for lung cancer based on feed-forward neural network regarding semiquantitative cytochemical analysis of alveolar macrophages
N. Minic, S. Zunic (Belgrade, Republic Of Serbia)
| |